Correlation Between Tcr2 Therapeutics and Icosavax
Can any of the company-specific risk be diversified away by investing in both Tcr2 Therapeutics and Icosavax at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tcr2 Therapeutics and Icosavax into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tcr2 Therapeutics and Icosavax, you can compare the effects of market volatilities on Tcr2 Therapeutics and Icosavax and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tcr2 Therapeutics with a short position of Icosavax. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tcr2 Therapeutics and Icosavax.
Diversification Opportunities for Tcr2 Therapeutics and Icosavax
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tcr2 and Icosavax is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Tcr2 Therapeutics and Icosavax in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Icosavax and Tcr2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tcr2 Therapeutics are associated (or correlated) with Icosavax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Icosavax has no effect on the direction of Tcr2 Therapeutics i.e., Tcr2 Therapeutics and Icosavax go up and down completely randomly.
Pair Corralation between Tcr2 Therapeutics and Icosavax
If you would invest (100.00) in Icosavax on November 29, 2024 and sell it today you would earn a total of 100.00 from holding Icosavax or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tcr2 Therapeutics vs. Icosavax
Performance |
| Timeline |
| Tcr2 Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
| Icosavax |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Tcr2 Therapeutics and Icosavax Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tcr2 Therapeutics and Icosavax
The main advantage of trading using opposite Tcr2 Therapeutics and Icosavax positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tcr2 Therapeutics position performs unexpectedly, Icosavax can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Icosavax will offset losses from the drop in Icosavax's long position.| Tcr2 Therapeutics vs. Affimed NV | Tcr2 Therapeutics vs. ADC Therapeutics SA | Tcr2 Therapeutics vs. Agenus Inc | Tcr2 Therapeutics vs. Revolution Medicines |
| Icosavax vs. Terns Pharmaceuticals | Icosavax vs. Amylyx Pharmaceuticals | Icosavax vs. Acumen Pharmaceuticals | Icosavax vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |